#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>
*ExistRefRange>
#ExistRefRangeTable> | Test Number
| Components
| Reference Interval
| | | Thallium, Urine - per volume
| 0-5 µg/L
| | | Thallium, Urine - per 24h
| Not Established
| | | Thallium, Urine - ratio to CRT
| Not Established
| | 0020473 | Creatinine, 24-Hour Urine
| | Age
| Male
| Female
| | 3-8 years
| 140-700 mg/d
| 140-700 mg/d
| | 9-12 years
| 300-1300 mg/d
| 300-1300 mg/d
| | 13-17 years
| 500-2300 mg/d
| 400-1600 mg/d
| | 18-50 years
| 1000-2500 mg/d
| 700-1600 mg/d
| | 51-80 years
| 800-2100 mg/d
| 500-1400 mg/d
| | 81 years and older
| 600-2000 mg/d
| 400-1300 mg/d
|
|
*ExistRefRangeTable>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Urinary thallium levels may reflect recent or chronic exposure and the presence of thallium in urine after acute exposure may persist for up to several weeks. Concentrations less than 5 µg/L are unlikely to cause adverse health effects while concentrations greater than 500 µg/L have been associated with clinical poisoning. After severe thallium poisoning reported symptoms have varying times of onset and include gastroenteritis, multi-organ failure and neurologic injury. Peripheral neuropathy and alopecia are well-documented effects of acute and chronic exposure. Human health effects from low level thallium exposure are unknown.
See Compliance Statement B: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
83018
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Thallium/Creatinine Ratio, Random, Urine (Thallium, Urine), TLU (Thallium, Urine) |
*ExistCrossReferences>